[Pharmacotherapy in pregnancy]

[Pharmacotherapy in pregnancy] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Pharmacotherapy in pregnancy] Abstract Text:

W E Paulus,

Between 1958 and 1961 approximately 10,000 children with severe limb defects were born, whose mothers had taken the somnifacient thalidomid. Since then, pharmaceutical agents in pregnancy are applied with legitimate caution by the pharmaceutical industry, physicians and patients, although often accompanied by irrational panic. According to statistical inquests, 15 to 50 percent of expectant mothers take pharmaceutical agents in the first trimester of pregnancy, often being not aware of their pregnancy. Considering the sensitive phase of organogenesis, the consequences may be particularly fatal in the first three months of pregnancy. After thalidomid more teratogenic pharmaceutical agents were discovered, i.e. coumarin derivates (e.g. warfarin), vitamin A and its derivates (e.g. isotretinoin), antifolates or anticonvulsants such as hydantoin or valproic acid. A number of other drugs are supposed to be potentially embryotoxic/fetotoxic, the effect of those pharmaceutical agents above all depending on dose and time of exposure. Case reports on malformations are available for numerous drugs, but studies with statistical validity are often missing. The pharmaceutical industry takes a legally safe position noting "contraindication" or at least "strict indication" in the consumer information. Concerning expectant mothers with chronic diseases like epilepsy, hypertension or bronchial asthma a therapeutic nihilism may lead to a dramatic deterioration of the disease, thereby causing high risks in fetal development. On the other hand numerous abortions without profound indications are carried out due to insufficient information of patients and medical staff on the real risks of a medication during early pregnancy. On principle reliable drugs should be preferred to new agents during fertile age of women. Special information centres for reproductive toxicology with corresponding data banks should be established and consulted, if an exposure with an insufficiently tested substance has taken place in ignorance of pregnancy.

[Pharmacotherapy in pregnancy] Publishing Authors By Initials

WE Paulus,

For similar female urogenital diseases and pregnancy complications: pregnancy complications: prenatal injuries: prenatal exposure delayed effects research abstracts see: female urogenital diseases and pregnancy complications: pregnancy complications: prenatal injuries: prenatal exposure delayed effects research

PUBMED ID PMID:

MEDLINE DATE:

[Pharmacotherapy in pregnancy] Journal Published:

PUBLICATION TYPE: Review

Journal: Therapeutische Umschau. Revue thérapeutique

VOLUME: 56

Page Numbers: 602-7

Journal Abbreviation:

ISSN: 0040-5930

DAY: 12

MONTH: Oct

YEAR: 1999

[Pharmacotherapy in pregnancy] Information

Number of References: 7

LANGUAGE: ger

NlmUniqueID: 407224

[Pharmacotherapy in pregnancy] Keywords Mesh Terms:

KEYWORDS: Prenatal Exposure Delayed Effects

MESH TERMS: drug therapy

Chemical & Substance for Abstract: [Pharmacotherapy in pregnancy] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Pharmacotherapy in pregnancy]

AFFILIATION: Beratungszentrum für Reproduktionstoxikologie, Roggenburg.

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ther Umsch

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pharmacotherapy in pregnancy Related Publications

• Acta Neuropathologica and their case reports.
• Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.
• Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort.
• Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease.
• Calcifications and the therapeutically irradiated breast.
• Classifying radiographic progression status in early rheumatoid arthritis patients using propensity scores to adjust for baseline differences.
• Comparing integrated care policy in Europe: Does policy matter?
• Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort.
• Decision making, impulsivity and time perception.
• Decision-making dysfunctions in psychiatry--altered homeostatic processing?
• Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
• Full configuration interaction study of the metal-insulator transition in model systems: Li(N) linear chains (N=2,4,6,8).
• Heritability of anterior cingulate response to conflict: an fMRI study in female twins.
• Higher variability of phosphene thresholds in migraineurs than in controls: a consecutive transcranial magnetic stimulation study.
• Impaired time perception and motor timing in stimulant-dependent subjects.
• Increased amygdala activation is related to heart rate during emotion processing in adolescent subjects.
• Infinite-layer iron oxide with a square-planar coordination.
• Lorazepam dose-dependently decreases risk-taking related activation in limbic areas.
• Manipulation of phosphene thresholds by transcranial direct current stimulation in man.
• Paired-pulse repetitive transcranial magnetic stimulation of the human motor cortex.
• Rosette-forming glioneuronal tumor of the fourth ventricle: Report of two cases with a differential diagnostic overview.
• Side-effects after combination therapy for Ewing's sarcoma.
• Skin thickness in the therapeutically irradiated breast.
• The complexity of care for patients with rheumatoid arthritis: metrics for better understanding chronic disease care.
• Theta burst stimulation of the motor cortex reduces laser-evoked pain perception.
• Time and decision making: differential contribution of the posterior insular cortex and the striatum during a delay discounting task.
• Transcranial direct current stimulation reveals inhibitory deficiency in migraine.
• Young adult stimulant users' increased striatal activation during uncertainty is related to impulsivity.
• [Applied gnathology (I): history of an oral rehabilitation]
• [Pharmacotherapy in pregnancy]